Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 21, 2024 04:19 ET | Source: Research and Markets

Dementia Associated With Alzheimer's Disease Market Research Report 2024: Comprehensive Insights About 80+ Companies and 100+ Pipeline Drugs

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
October 22, 2024 09:43 ET | Source: Research and Markets

Neurologic Disorders Therapeutics Strategic Business Report 2024: Global Market to Reach $149.7 Billion by 2030, Driven by Development of Regenerative Medicine and Stem Cell Therapies

Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Neurologic Disorders Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
September 20, 2024 08:02 ET | Source: Research and Markets

Amyotrophic Lateral Sclerosis Market Report (2024 Edition): Size, Trends, Opportunities and Forecast by Treatment Type, Drug, Distribution Channel, and Country (2020-2030)

Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market (2024 Edition): Size, Trends, Opportunities and Forecast by Treatment Type, Drug, Distribution Channel, and...
March 08, 2024 04:28 ET | Source: Research and Markets

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
January 19, 2021 09:00 ET | Source: Neuropathix, Inc.

Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant

DOYLESTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced the...
June 18, 2018 06:00 ET | Source: BCC Research

Growth in Neuroprotective Agents Market Projected to 2022

WELLESLEY, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Longer life spans, the increasing prevalence of neurological disorders (particularly neurodegenerative diseases), stroke and traumatic central...
August 11, 2015 13:50 ET | Source: KannaLife Sciences, Inc.

Kannalife Sciences Discusses Orphan Drug Opportunity for KLS-13019

NEW YORK, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc., a Phyto-Medical Company, describes orphan drug opportunity for KLS-13019, a Novel Functionalized 1,3-Benzene Diol for the...
August 06, 2015 13:54 ET | Source: KannaLife Sciences, Inc.

KannaLife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents

NEW YORK, Aug. 6, 2015 (GLOBE NEWSWIRE) -- KannaLife Sciences, Inc., a Phyto-Medical Company, announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – 'Novel Functionalized...